Literature DB >> 27412876

Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?

M Eugenia Socías1,2, Nora Volkow3, Evan Wood1,2.   

Abstract

Entities:  

Keywords:  Addiction medicine; cascade of care; evidence-based; performance measures; quality measurement; substance use disorders

Mesh：

Year:  2016        PMID： 27412876      PMCID： PMC5321168          DOI： 10.1111/add.13479

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  11 in total

Review 1.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease.

Authors:  Louisa Degenhardt; Wayne Hall
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

Review 2.  The Affordable Care Act: an opportunity for improving care for substance use disorders?

Authors:  Katherine E Watkins; Carrie M Farmer; David De Vries; Kimberly A Hepner
Journal:  Psychiatr Serv       Date:  2014-12-01       Impact factor: 3.084

3.  Medication-assisted therapies--tackling the opioid-overdose epidemic.

Authors:  Nora D Volkow; Thomas R Frieden; Pamela S Hyde; Stephen S Cha
Journal:  N Engl J Med       Date:  2014-04-23       Impact factor: 91.245

4.  A cascade of care for diabetes in the United States: visualizing the gaps.

Authors:  Mohammed K Ali; Kai McKeever Bullard; Edward W Gregg; Carlos Del Rio
Journal:  Ann Intern Med       Date:  2014-11-18       Impact factor: 25.391

Review 5.  The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.

Authors:  Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

6.  Physician education in addiction medicine.

Authors:  Evan Wood; Jeffrey H Samet; Nora D Volkow
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

Review 7.  Constructing the cascade of HIV care: methods for measurement.

Authors:  Noah Haber; Deenan Pillay; Kholoud Porter; Till Bärnighausen
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

Review 8.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

Review 9.  The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.

Authors:  Baligh R Yehia; Asher J Schranz; Craig A Umscheid; Vincent Lo Re
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

10.  Training in addiction medicine should be standardised and scaled up.

Authors:  J Klimas
Journal:  BMJ       Date:  2015-07-28
View more
  27 in total

1.  The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

Authors:  M Eugenia Socias; Keith Ahamad; Bernard Le Foll; Ron Lim; Julie Bruneau; Benedikt Fischer; T Cameron Wild; Evan Wood; Didier Jutras-Aswad
Journal:  Contemp Clin Trials       Date:  2018-04-05       Impact factor: 2.226

2.  Development of a Cascade of Care for responding to the opioid epidemic.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson
Journal:  Am J Drug Alcohol Abuse       Date:  2019-01-24       Impact factor: 3.829

3.  A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.

Authors:  Osama M Ahmed; Jodi A Mao; Stephen R Holt; Kathryn Hawk; Gail D'Onofrio; Shara Martel; Edward R Melnick
Journal:  J Subst Abuse Treat       Date:  2019-05-07

4.  Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use.

Authors:  Nora Jacobson; Julie Horst; Liam Wilcox-Warren; Alex Toy; Hannah K Knudsen; Randy Brown; Eric Haram; Lynn Madden; Todd Molfenter
Journal:  J Behav Health Serv Res       Date:  2020-10       Impact factor: 1.505

5.  Opioids and HIV Infection: From Pain Management to Addiction Treatment.

Authors:  Chinazo O Cunningham
Journal:  Top Antivir Med       Date:  2018-04

6.  Trajectories of retention in opioid agonist therapy in a Canadian setting.

Authors:  M Eugenia Socías; Huiru Dong; Evan Wood; Rupinder Brar; Lindsey Richardson; Kanna Hayashi; Thomas Kerr; M-J Milloy
Journal:  Int J Drug Policy       Date:  2020-02-09

7.  Monitoring opioid addiction and treatment: Do you know if your population is engaged?

Authors:  José Tomás Prieto; Dean McEwen; Arthur J Davidson; Alia Al-Tayyib; Lisa Gawenus; Sridhar R Papagari Sangareddy; Joshua Blum; Seth Foldy; Judith C Shlay
Journal:  Drug Alcohol Depend       Date:  2019-07-06       Impact factor: 4.492

8.  Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.

Authors:  Hillary Samples; Arthur Robin Williams; Mark Olfson; Stephen Crystal
Journal:  J Subst Abuse Treat       Date:  2018-09-07

Review 9.  Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.

Authors:  Laura Fanucchi; Sandra A Springer; P Todd Korthuis
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

10.  Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network.

Authors:  Kevin A Hallgren; Elizabeth Witwer; Imara West; Laura-Mae Baldwin; Dennis Donovan; Brenda Stuvek; Gina A Keppel; Brenda Mollis; Kari A Stephens
Journal:  J Subst Abuse Treat       Date:  2019-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.